127 related articles for article (PubMed ID: 38698701)
21. Echotexture Analysis of Prostate Parenchyma for Detection of Benign Prostatic Hyperplasia in Dogs.
Khanbazi MH; Mogheiseh A; Ahrari Khafi MS; Nazifi S; Derakhshandeh N; Golchin-Rad K
Top Companion Anim Med; 2021 Mar; 42():100501. PubMed ID: 33249242
[TBL] [Abstract][Full Text] [Related]
22. Decreased prostatic secretory function in canine benign prostatic hyperplasia is not due to decreased levels of muscarinic cholinergic receptors.
Lepor H; Berry SJ
J Urol; 1984 Apr; 131(4):803-5. PubMed ID: 6200613
[TBL] [Abstract][Full Text] [Related]
23. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of biomarker canine-prostate specific arginine esterase (CPSE) for the diagnosis of benign prostatic hyperplasia.
Pinheiro D; Machado J; Viegas C; Baptista C; Bastos E; Magalhães J; Pires MA; Cardoso L; Martins-Bessa A
BMC Vet Res; 2017 Mar; 13(1):76. PubMed ID: 28335775
[TBL] [Abstract][Full Text] [Related]
25. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
26. Validation of a model to develop a symptom index for benign prostatic hyperplasia in dogs.
Zambelli D; Cunto M; Gentilini F
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():229-31. PubMed ID: 23279506
[TBL] [Abstract][Full Text] [Related]
27. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
28. Computed Tomography of the Prostate Gland in Healthy Intact Dogs and Dogs with Benign Prostatic Hyperplasia.
Pasikowska J; Hebel M; Niżański W; Nowak M
Reprod Domest Anim; 2015 Oct; 50(5):776-83. PubMed ID: 26303126
[TBL] [Abstract][Full Text] [Related]
29. Treatment of experimentally induced benign prostatic hyperplasia with Tadalafil and castration in dogs.
Dearakhshandeh N; Mogheiseh A; Nazifi S; Ahrari Khafi MS; Abbaszadeh Hasiri M; Golchin-Rad K
Theriogenology; 2020 Jan; 142():236-245. PubMed ID: 31711694
[TBL] [Abstract][Full Text] [Related]
30. Sperm quality and selected biochemical parameters of seminal fluid in dogs with benign prostatic hyperplasia.
Krakowski L; Wąchocka A; Brodzki P; Wrona Z; Piech T; Wawron W; Chałabis-Mazurek A
Anim Reprod Sci; 2015 Sep; 160():120-5. PubMed ID: 26275963
[TBL] [Abstract][Full Text] [Related]
31. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
32. The effects of osaterone acetate on clinical signs and prostate volume in dogs with benign prostatic hyperplasia.
Socha P; Zduńczyk S; Tobolski D; Janowski T
Pol J Vet Sci; 2018 Dec; 21(4):559-566. PubMed ID: 30605276
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical Expression of Angiogenic Factors by Neoplastic Epithelial Cells Is Associated With Canine Prostatic Carcinogenesis.
Palmieri C
Vet Pathol; 2015 Jul; 52(4):607-13. PubMed ID: 25281650
[TBL] [Abstract][Full Text] [Related]
34. Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.
Leoci R; Aiudi G; Silvestre F; Lissner E; Lacalandra GM
Prostate; 2014 Aug; 74(11):1132-41. PubMed ID: 24913937
[TBL] [Abstract][Full Text] [Related]
35. Porous Se@SiO
Yang BY; Deng GY; Zhao RZ; Dai CY; Jiang CY; Wang XJ; Jing YF; Liu XJ; Xia SJ; Han BM
Acta Biomater; 2019 Apr; 88():392-405. PubMed ID: 30753941
[TBL] [Abstract][Full Text] [Related]
36. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog.
Goericke-Pesch S; Wilhelm E; Ludwig C; Desmoulins PO; Driancourt MA; Hoffmann B
Theriogenology; 2010 Apr; 73(7):920-6. PubMed ID: 20097413
[TBL] [Abstract][Full Text] [Related]
38. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
[TBL] [Abstract][Full Text] [Related]
39. Histopathological Terminology Standards for the Reporting of Prostatic Epithelial Lesions in Dogs.
Palmieri C; Foster RA; Grieco V; Fonseca-Alves CE; Wood GA; Culp WTN; Murua Escobar H; De Marzo AM; Laufer-Amorim R
J Comp Pathol; 2019 Aug; 171():30-37. PubMed ID: 31540623
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress in benign prostatic hyperplasia and prostate cancer.
Pace G; Di Massimo C; De Amicis D; Corbacelli C; Di Renzo L; Vicentini C; Miano L; Tozzi Ciancarelli MG
Urol Int; 2010; 85(3):328-33. PubMed ID: 20484887
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
